blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP0711158

EP0711158 - METHOD OF TREATING ATHEROSCLEROSIS OR RESTENOSIS USING MICROTUBULE STABILIZING AGENT [Right-click to bookmark this link]
StatusPatent maintained as amended
Status updated on  20.06.2008
Database last updated on 11.09.2024
Most recent event   Tooltip20.06.2008Patent maintained (B2 publication)published on 23.07.2008  [2008/30]
Applicant(s)For all designated states
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
The National Institute of Health, Office of Technology Transfer, 6011 Executive Boulevard, Suite 325
Rockville, MD 20852 / US
[2008/30]
Former [2003/49]For all designated states
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
The National Institute of Health, Office of Technology Transfer, 6011 Executive Boulevard, Suite 325
Rockville, MD 20852 / US
Former [1996/20]For all designated states
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health, Office of Technology Transfer, Box 13, 6011 Executive Boulevard, Suite 325
Rockville, MD 20852 / US
Inventor(s)01 / KINSELLA, James L.
412 Old Trail
Baltimore, MD 21212 / US
02 / SOLLOTT, Steven J.
2373 Sundew Terrace
Baltimore, MD 21209 / US
[1996/20]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[N/P]
Former [1996/20]VOSSIUS & PARTNER
Postfach 86 07 67
81634 München / DE
Application number, filing date94924519.529.07.1994
[1996/20]
WO1994US08578
Priority number, dateUS1993009906729.07.1993         Original published format: US 99067
[1996/20]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9503795
Date:09.02.1995
Language:EN
[1995/07]
Type: A1 Application with search report 
No.:EP0711158
Date:15.05.1996
Language:EN
The application published by WIPO in one of the EPO official languages on 09.02.1995 takes the place of the publication of the European patent application.
[1996/20]
Type: B1 Patent specification 
No.:EP0711158
Date:03.12.2003
Language:EN
[2003/49]
Type: B2 New European patent specification 
No.:EP0711158
Date:23.07.2008
Language:EN
[2008/30]
Search report(s)International search report - published on:EP09.02.1995
ClassificationIPC:A61K31/337, A61K33/00, A61P9/10
[2003/14]
CPC:
A61K31/337 (EP,US); A61K31/335 (EP,US); A61L31/16 (EP,US);
A61P3/10 (EP); A61P9/00 (EP); A61P9/10 (EP);
A61P9/12 (EP); A61K9/0024 (EP,US); A61L2300/416 (EP,US);
A61L2300/602 (EP,US) (-)
Former IPC [1996/20]A61K31/335, A61K31/54, A61K31/535, A61K31/495, A61K31/445, A61K31/40
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1996/20]
TitleGerman:VERFAHREN ZUR BEHANDLUNG ATHEROSKLEROSE ODER RESTENOSE MIT HILFE EINES MIKROTUBULUSSTABILISATORS[2003/48]
English:METHOD OF TREATING ATHEROSCLEROSIS OR RESTENOSIS USING MICROTUBULE STABILIZING AGENT[1996/20]
French:PROCEDE DE TRAITEMENT DE L'ATHEROSCLEROSE OU DE LA RESTENOSE AU MOYEN D'UN AGENT DE STABILISATION DES MICROTUBULES[1996/20]
Former [1996/20]METHODE ZUR BEHANDLUNG ARTHEROSCLEROSE ODER RESTENOSE MIT HILFE EINES MIKROTUBULSTASBILISATORES
Entry into regional phase23.02.1996National basic fee paid 
23.02.1996Designation fee(s) paid 
23.02.1996Examination fee paid 
Examination procedure10.02.1995Request for preliminary examination filed
International Preliminary Examining Authority: EP
23.02.1996Examination requested  [1996/20]
16.12.1997Despatch of a communication from the examining division (Time limit: M06)
26.06.1998Reply to a communication from the examining division
27.01.2000Despatch of a communication from the examining division (Time limit: M06)
16.10.2000Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
22.12.2000Reply to a communication from the examining division
19.03.2002Despatch of a communication from the examining division (Time limit: M04)
15.07.2002Reply to a communication from the examining division
27.03.2003Communication of intention to grant the patent
02.10.2003Fee for grant paid
02.10.2003Fee for publishing/printing paid
Divisional application(s)EP00128626.9  / EP1118325
EP05027952.0  / EP1649853
Opposition(s)Opponent(s)01  02.09.2004  10.09.2004  ADMISSIBLE
CONOR MEDSYSTEMS
1003 Hamilton Court
Menlo Park, CA94025 / US
Opponent's representative
Bijvank, Koen Mattijs Lodewiek, et al, et al
V.O.
Johan de Wittlaan 7
2517 JR Den Haag / NL
 02  03.09.2004  26.10.2004  ADMISSIBLE
B. Braun Melsungen AG
Carl-Braun-Str.1
34212 Melsungen / DE
Opponent's representative
Arth, Hans-Lothar, et al, et al
ABK Patent Attorneys
Jasminweg 9
14052 Berlin / DE
 [N/P]
Former [2008/24]
Opponent(s)01  02.09.2004  10.09.2004  ADMISSIBLE
CONOR MEDSYSTEMS
1003 Hamilton Court
Menlo Park, CA94025 / US
Opponent's representative
Bijvank, Koen Mattijs Lodewiek, et al, et al
Vereenigde P.O. Box 87930
2508 DH Den Haag / NL
 02  03.09.2004  26.10.2004  ADMISSIBLE
B. Braun Melsungen AG
Carl-Braun-Str.1
34212 Melsungen / DE
Opponent's representative
Arth, Hans-Lothar, et al, et al
ABK Patent Attorneys Jasminweg 9
14052 Berlin / DE
Former [2006/24]
Opponent(s)01  02.09.2004  10.09.2004  ADMISSIBLE
CONOR MEDSYSTEMS
1003 Hamilton Court
Menlo Park, CA94025 / US
Opponent's representative
Bijvank, Koen Mattijs Lodewiek, et al, et al
Vereenigde P.O. Box 87930
2508 DH Den Haag / NL
 02  03.09.2004  26.10.2004  ADMISSIBLE
B. Braun Melsungen AG
Carl-Braun-Str.1
34212 Melsungen / DE
Opponent's representative
Arth, Hans-Lothar, et al, et al
Arth, Bucher & Kollegen Patentanwälte Am Klopferspitz 19 (IZB)
82152 München-Martiensried / DE
Former [2005/45]
Opponent(s)01  02.09.2004  10.09.2004  ADMISSIBLE
CONOR MEDSYSTEMS
1003 Hamilton Court
Menlo Park, CA94025 / US
Opponent's representative
Helbig, Christian, Dr. Dipl.-Biol.
Frohwitter Patent- und Rechtsanwälte Possartstrasse 20
81679 München / DE
 02  03.09.2004  26.10.2004  ADMISSIBLE
B. Braun Melsungen AG
Carl-Braun-Str.1
34212 Melsungen / DE
Opponent's representative
Arth, Hans-Lothar, et al, et al
Arth, Bucher & Kollegen Patentanwälte Am Klopferspitz 19 (IZB)
82152 München-Martiensried / DE
Former [2005/44]
Opponent(s)01  02.09.2004  10.09.2004  ADMISSIBLE
CONOR MEDSYSTEMS
1003 Hamilton Court
Menlo Park, CA94025 / US
Opponent's representative
Helbig, Christian, Dr. Dipl.-Biol.
Frohwitter Patent- und Rechtsanwälte Possartstrasse 20
81679 München / DE
 02  03.09.2004  26.10.2004  ADMISSIBLE
B. Braun Melsungen AG
Carl-Braun-Str.1
34212 Melsungen / DE
Opponent's representative
Arth, Hans-Lothar, et al, et al
Arth, Bucher & Kollegen, Am Klopferspitz 19
82152 Martinsried / DE
Former [2004/45]
Opponent(s)01  02.09.2004  10.09.2004  ADMISSIBLE
CONOR MEDSYSTEMS
1003 Hamilton Court
Menlo Park, CA94025 / US
Opponent's representative
Helbig, Christian, Dr. Dipl.-Biol.
Frohwitter Patent- und Rechtsanwälte Possartstrasse 20
81679 München / DE
 02  03.09.2004   
B. Braun Melsungen AG
Carl-Braun-Str.1
34212 Melsungen / DE
Opponent's representative
Hinz, Claus-Dieter, Dipl.-Ing. Walther, Walther & Hinz, Patentanwälte - European Patent Attorneys
Postfach 41 01 45
34063 Kassel / DE
Former [2004/44]
Opponent(s)01  02.09.2004  10.09.2004  ADMISSIBLE
CONOR MEDSYSTEMS
1003 Hamilton Court
Menlo Park, CA94025 / US
Opponent's representative
Helbig, Christian, Dr. Dipl.-Biol.
Frohwitter Patent- und Rechtsanwälte Possartstrasse 20
81679 München / DE
 02  03.09.2004   
B. Braun Melsungen AG
Carl-Braun-Str.1
34212 Melsungen / DE
Opponent's representative
WALTHER, WALTHER & HINZ Patentanwälte
Heimradstrasse 2
34130 Kassel / DE
02.11.2004Invitation to proprietor to file observations on the notice of opposition
28.11.2005Reply of patent proprietor to notice(s) of opposition
25.10.2007Legal effect of interlocutory decision in opposition
25.10.2007Date of oral proceedings
22.11.2007Despatch of interlocutory decision in opposition
22.11.2007Despatch of minutes of oral proceedings
13.03.2008Despatch of communication that the patent will be maintained as amended
09.06.2008Fee for printing new specification paid
Request for further processing for:22.12.2000Request for further processing filed
22.12.2000Full payment received (date of receipt of payment)
Request granted
15.01.2001Decision despatched
Fees paidRenewal fee
20.06.1996Renewal fee patent year 03
14.07.1997Renewal fee patent year 04
05.10.1998Renewal fee patent year 05
02.07.1999Renewal fee patent year 06
03.07.2000Renewal fee patent year 07
05.07.2001Renewal fee patent year 08
04.07.2002Renewal fee patent year 09
23.07.2003Renewal fee patent year 10
Penalty fee
Additional fee for renewal fee
31.07.199805   M06   Fee paid on   05.10.1998
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[DYX]US5157049  (HAUGWITZ RUDIGER D [US], et al) [DY] 1-11,14-24 * the whole document * * the whole document *[X] 12,13
 [XY]  - CHALDAKOV G. N., "Antitubulins- A New Therapeutic Approach for Atherosclerosis?", ATHEROSCLEROSIS, (1982), vol. 44, pages 385 - 90 [X] 1,4,7,10-12,14,17,20,23,24 * the whole document * * the whole document * [Y] 2,3,5,6,8,9,13,15,16,18,19,21,22
 [XY]  - BARD ET AL, "Normolipemic Activities of Acrylophenone Derivatives with Antimicrotubular Properties", METH. AND FIND. CLIN. PHARMACOL., (1985), vol. 7, no. 4, pages 183 - 7 [X] 1,4,7,10-12,14,17,20,23,24 * page 186 * * the whole document * [Y] 2,3,5,6,8,9,13,15,16,18,19,21,22
 [DXY]  - CURRIER ET AL, "Colchicine Inhibits Restenosis After Iliac Angioplasty in the Atherosclerotic Rabbit", CIRCULATION, (1989), vol. 80/S-II, page 66 [DX] 1,4,7,10-12,14,17,20,23,24 * the whole document * * the whole document * [Y] 2,3,5,6,8,9,13,15,16,18,19,21,22
 [Y]  - LÖVQUIST ET AL, "Pathophysiological Mechanism for Restenosis Following Coronary Angioplasty: Possible Preventive Alternatives", J. OF INT. MED., (1993), vol. 233, pages 215 - 26 [Y] 1-11,14-24 * page 221, column 2, paragraph 2 *
 [X]  - The Merck Index, MERCK CO. INC., (1989) [X] 12,13 * no.9049; page 1435 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.